Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Hofseth Biocare A stock price, quote, forecast and news

HBC.OL
NO0010598683
A1JWL4

Price

2.06
Today +/-
+0.00
Today %
+1.96 %
P

Hofseth Biocare A stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Hofseth Biocare A stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Hofseth Biocare A stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Hofseth Biocare A stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Hofseth Biocare A's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Hofseth Biocare A Stock Price History

DateHofseth Biocare A Price
9/11/20242.06 undefined
9/10/20242.02 undefined
9/9/20241.99 undefined
9/6/20242.00 undefined
9/5/20241.95 undefined
9/4/20241.93 undefined
9/3/20241.98 undefined
9/2/20241.96 undefined
8/30/20242.02 undefined
8/29/20242.05 undefined
8/28/20242.10 undefined
8/27/20241.97 undefined
8/26/20242.05 undefined
8/23/20242.14 undefined
8/22/20242.05 undefined
8/21/20242.02 undefined
8/20/20242.08 undefined
8/19/20242.10 undefined
8/16/20241.98 undefined
8/15/20241.95 undefined

Hofseth Biocare A Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Hofseth Biocare A, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Hofseth Biocare A from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Hofseth Biocare A’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Hofseth Biocare A. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Hofseth Biocare A’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Hofseth Biocare A’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Hofseth Biocare A’s growth potential.

Hofseth Biocare A Revenue, EBIT and net profit per share

DateHofseth Biocare A RevenueHofseth Biocare A EBITHofseth Biocare A Net Income
2023194.87 M undefined-123.52 M undefined-106.68 M undefined
2022120.45 M undefined-127.17 M undefined-137.39 M undefined
202187.62 M undefined-116.21 M undefined-126.46 M undefined
202069.25 M undefined-90.11 M undefined-102.09 M undefined
201967.78 M undefined-79.57 M undefined-89.22 M undefined
201860.74 M undefined-77.7 M undefined-84.77 M undefined
201766.23 M undefined-11.2 M undefined-16.48 M undefined
201620.2 M undefined-137.03 M undefined-147.45 M undefined
201555.14 M undefined-91.29 M undefined-100.19 M undefined
201419.77 M undefined-59.43 M undefined-66.92 M undefined
201362.94 M undefined-47.49 M undefined-52.14 M undefined
201226.02 M undefined-58.04 M undefined-73.86 M undefined
20111.18 M undefined-24.32 M undefined-19.04 M undefined
2010170,000 undefined-12.91 M undefined-9.39 M undefined

Hofseth Biocare A Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20102011201220132014201520162017201820192020202120222023
0126621955206660676987120194
--2,500.00138.46-69.35189.47-63.64230.00-9.0911.672.9926.0937.9361.67
--7.6959.6826.3227.27-185.0016.6720.00-18.842.3023.3322.68
00237515-37111201322844
-12-24-58-47-59-91-137-11-77-79-90-116-127-123
--2,400.00-223.08-75.81-310.53-165.45-685.00-16.67-128.33-117.91-130.43-133.33-105.83-63.40
-9-19-73-52-66-100-147-16-84-89-102-126-137-106
-111.11284.21-28.7726.9251.5247.00-89.12425.005.9514.6123.538.73-22.63
28.142.4256.972.0890.66105.42146.19234.31258.99307.29333.65357.83374.74395.08
--------------
Details

Keystats

ⓘ

Revenue and Growth

The Hofseth Biocare A Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Hofseth Biocare A is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (k)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
20102011201220132014201520162017201820192020202120222023
                           
2.518.52.242.5428.8716.1742.0748.6493.21170.7147.2129.8820.87
0.10.116.547.544.751.982.4926.714.75.5414.2710.0914.0714.85
0007.33.77000000000
00.46.125.851.0450.8215.5916.8629.433.9973.390.81116.5382.54
1221.218.76.13.516.063.249.267.585.1113.1922.215.2712.74
14.640.243.590.7105.6187.7337.4894.89100.32137.85271.47170.31175.75131
47.667.172.188.584.6981.47104.6868.0967.36128.35137.96185.83168.79165.7
00000.891.440.963.652.912.467.286.785.938.13
6005008006000000000000
2831.531.617.718.3515.2516.2317.6117.3624.3542.4353.0660.5955.28
07.57.57.507.4600000000
3.811.5000000-00000-0
80118.1112114.3103.92105.62121.8789.3587.63155.16187.66245.66235.28259.12
94.6158.3155.5205209.53193.35159.35184.24187.95293.01459.13415.97411.03390.12
                           
38.757.257.277.598.04110.41233.5233.5294.84325.823.583.583.953.95
47.463.11.70000000.83236.71137.49144.7737.88
-10.10-10.8-14.9-18.45-77.22-179.28-195.75-208.12-208.2215.48000
00.20.2000000-08.68000
00000000000000
76120.548.362.679.5933.1954.2237.7586.72118.43264.45141.06148.7241.83
6.910.531.535.630.355.4425.1551.9332.1129.7184.96124.17145.7555.16
00000000000000
1.83.87.910.67.136.746.213.811.4913.099.5712.2513.08157.03
00000000000000
5.51.268.561.155.3812.5628.8137.0827.9128.9611.6514.5213.439.69
14.215.5107.9107.392.874.7460.15102.8171.5171.75106.18150.93172.23251.88
2.922.4035.845.0486.0745.6421.5112.9292.0285.42123.3189.9697.1
00000000000000
1.500000022.8317.4711.493.771.350.810
4.422.4035.845.0486.0745.6444.3430.39103.5189.19124.6690.7797.1
18.637.9107.9143.1137.84160.8105.79147.16101.9175.26195.37275.6263348.98
94.6158.4156.2205.7217.43194160.01184.9188.62293.69459.82416.66411.72390.81
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Hofseth Biocare A provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Hofseth Biocare A's financial health and stability.

Assets

Hofseth Biocare A's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Hofseth Biocare A must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Hofseth Biocare A after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Hofseth Biocare A's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20102011201220132014201520162017201820192020202120222023
-13-25-63-52-66-100-147-16-84-89-102-126-137-106
0171214162621222726293035
00000000000000
037-44-2078471730224255253
010712127-48389997
000771063278997
00000000000000
-12-19-48-76-617-67-25-28-31-61-61-45-9
-24-29-17-29-10-11-42-13-9-20-54-37-17-23
-19-30-17-13-10-12-4263-9-19-60-37-17-23
400160007700-5000
00000000000000
5144945213730-8-190-31-13-1532
2855052565730721082450700
33654991703096-124596199-234524
020-6-8-11-8-4-7-11-14-9-10-7
0-6000000000000
116-161-126-122564578-122-17-8
-36.65-49-65.12-105.95-71.52-3.87-109.81-39.29-38.46-51.11-116.09-99.53-62.95-33.4
00000000000000

Hofseth Biocare A stock margins

The Hofseth Biocare A margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Hofseth Biocare A. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Hofseth Biocare A.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Hofseth Biocare A's sales revenue. A higher gross margin percentage indicates that the Hofseth Biocare A retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Hofseth Biocare A's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Hofseth Biocare A's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Hofseth Biocare A's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Hofseth Biocare A. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Hofseth Biocare A's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Hofseth Biocare A Margin History

Hofseth Biocare A Gross marginHofseth Biocare A Profit marginHofseth Biocare A EBIT marginHofseth Biocare A Profit margin
202322.68 %-63.38 %-54.74 %
202223.67 %-105.58 %-114.07 %
20212.86 %-132.64 %-144.34 %
202019.73 %-130.12 %-147.42 %
20191.22 %-117.4 %-131.63 %
201820.38 %-127.92 %-139.56 %
201717.07 %-16.9 %-24.87 %
2016-185.53 %-678.25 %-729.81 %
201527.4 %-165.57 %-181.72 %
201426.05 %-300.61 %-338.5 %
201359.77 %-75.45 %-82.84 %
20127.88 %-223.06 %-283.86 %
201161.02 %-2,061.02 %-1,613.56 %
2010100 %-7,594.12 %-5,523.53 %

Hofseth Biocare A Stock Sales Revenue, EBIT, Earnings per Share

The Hofseth Biocare A earnings per share therefore indicates how much revenue Hofseth Biocare A has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Hofseth Biocare A earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Hofseth Biocare A's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Hofseth Biocare A’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Hofseth Biocare A's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Hofseth Biocare A Revenue, EBIT and net profit per share

DateHofseth Biocare A Sales per ShareHofseth Biocare A EBIT per shareHofseth Biocare A Earnings per Share
20230.49 undefined-0.31 undefined-0.27 undefined
20220.32 undefined-0.34 undefined-0.37 undefined
20210.24 undefined-0.32 undefined-0.35 undefined
20200.21 undefined-0.27 undefined-0.31 undefined
20190.22 undefined-0.26 undefined-0.29 undefined
20180.23 undefined-0.3 undefined-0.33 undefined
20170.28 undefined-0.05 undefined-0.07 undefined
20160.14 undefined-0.94 undefined-1.01 undefined
20150.52 undefined-0.87 undefined-0.95 undefined
20140.22 undefined-0.66 undefined-0.74 undefined
20130.87 undefined-0.66 undefined-0.72 undefined
20120.46 undefined-1.02 undefined-1.3 undefined
20110.03 undefined-0.57 undefined-0.45 undefined
20100.01 undefined-0.46 undefined-0.33 undefined

Hofseth Biocare A business model

Hofseth Biocare A is one of the most popular companies on Eulerpool.com.

Hofseth Biocare A Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Hofseth Biocare A historical P/E ratio, EBIT, and P/S ratio.

Hofseth Biocare A shares outstanding

The number of shares was Hofseth Biocare A in 2023 — This indicates how many shares 395.081 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Hofseth Biocare A earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Hofseth Biocare A's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Hofseth Biocare A’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Hofseth Biocare A's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Hofseth Biocare A.

Hofseth Biocare A latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2015-0.06 -0.23  (-279.59 %)2015 Q2
3/31/2015-0.07 -0.19  (-168.71 %)2015 Q1
12/31/2014-0.14 -0.29  (-105.07 %)2014 Q4
9/30/2014-0.09 -0.16  (-75.94 %)2014 Q3
6/30/20140 -0.19  (0 %)2014 Q2
12/31/20130 0  (0 %)2013 Q4
12/31/2012-0.03 -0.28  (-825.73 %)2012 Q4
9/30/2012-0.06 -0.12  (-98.05 %)2012 Q3
6/30/2012-0.03 -0.17  (-462.05 %)2012 Q2
3/31/2012-0.08 -0.24  (-196.94 %)2012 Q1
1
2

Eulerpool ESG Scorecard© for the Hofseth Biocare A stock

Eulerpool World ESG Rating (EESG©)

73/ 100

🌱 Environment

79

👫 Social

64

🏛️ Governance

75

Environment

Scope 1 - Direct Emissions
16,918
Scope 2 - Indirect emissions from purchased energy
331,560
Scope 3 - Indirect emissions within the value chain
1,090,280
Total CO₂ emissions
348,478
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
✅
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
✅
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
✅
Water consumption and efficiency
✅

Social

Percentage of female employees51.7
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol✅
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement✅
Call Back Policies❌
Antitrust law✅

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Hofseth Biocare A list of shareholders

%
Name
Stocks
Change
Date
5.68238 % Novogratz (Amy)22,450,00022,450,00012/31/2022
5.17164 % Aqua Spark Cooperative UA20,432,1528,332,1527/3/2022
20.15150 % HighValue Partners AG79,614,75679,614,7564/5/2024
2.78424 % Brilliant Invest AS11,000,000012/31/2023
17.54392 % Bonafide Wealth Management AG69,312,69302/29/2024
17.54075 % RH INDUSTRI AS69,300,190012/31/2023
14.97834 % HOFSETH INTERNATIONAL AS59,176,565-435,20712/31/2023
10.36530 % Yokorei Co Ltd40,951,333012/31/2023
1.29508 % BlackRock Investment Management (UK) Ltd.5,116,623011/30/2023
0.87409 % Bomi Framroze Holding AS3,453,370200,00012/31/2023
1
2
3

Most common questions regarding Hofseth Biocare A

What is the P/E ratio of Hofseth Biocare A 2024?

The P/E ratio cannot be calculated for Hofseth Biocare A at the moment.

What is the P/S ratio of Hofseth Biocare A 2024?

The P/S cannot be calculated for Hofseth Biocare A currently.

What is the AlleAktien quality score of Hofseth Biocare A?

The AlleAktien quality score for Hofseth Biocare A is 6/10.

What is the revenue of Hofseth Biocare A 2024?

The revenue cannot currently be calculated for Hofseth Biocare A.

How high is the profit of Hofseth Biocare A 2024?

The profit cannot currently be calculated for Hofseth Biocare A.

What is the business model of Hofseth Biocare A

No history available for Hofseth Biocare A.

What is the Hofseth Biocare A dividend?

Hofseth Biocare A pays a dividend of 0 NOK distributed over payouts per year.

How often does Hofseth Biocare A pay dividends?

The dividend cannot currently be calculated for Hofseth Biocare A or the company does not pay out a dividend.

What is the Hofseth Biocare A ISIN?

The ISIN of Hofseth Biocare A is NO0010598683.

What is the Hofseth Biocare A WKN?

The WKN of Hofseth Biocare A is A1JWL4.

What is the Hofseth Biocare A ticker?

The ticker of Hofseth Biocare A is HBC.OL.

How much dividend does Hofseth Biocare A pay?

Over the past 12 months, Hofseth Biocare A paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Hofseth Biocare A is expected to pay a dividend of 0 NOK.

What is the dividend yield of Hofseth Biocare A?

The current dividend yield of Hofseth Biocare A is .

When does Hofseth Biocare A pay dividends?

Hofseth Biocare A pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Hofseth Biocare A?

Hofseth Biocare A paid dividends every year for the past 0 years.

What is the dividend of Hofseth Biocare A?

For the upcoming 12 months, dividends amounting to 0 NOK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Hofseth Biocare A located?

Hofseth Biocare A is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hofseth Biocare A kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hofseth Biocare A from 9/13/2024 amounting to 0 NOK, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.

When did Hofseth Biocare A pay the last dividend?

The last dividend was paid out on 9/13/2024.

What was the dividend of Hofseth Biocare A in the year 2023?

In the year 2023, Hofseth Biocare A distributed 0 NOK as dividends.

In which currency does Hofseth Biocare A pay out the dividend?

The dividends of Hofseth Biocare A are distributed in NOK.

All fundamentals about Hofseth Biocare A

Our stock analysis for Hofseth Biocare A Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hofseth Biocare A Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.